Clinical Trial Update: Safety, Three Batches Consistency and Immunity Duration of the Post-marketing Inactivated Enterovirus Type 71 (EV71) Vaccine in Children Aged 6-71 Months [Phase 4]

View source ↗

Summary

Phase 4 trial updating safety, three-batch consistency, and immunity duration for the inactivated EV71 vaccine in children aged 6-71 months. It reports post-mar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Foot and Mouth Disease

Drugs mentioned

• Enterovirus Type 71 vaccine (inactivated) (Enterovirus Type 71 vaccine)

Snippet

Sponsor: Beijing Chaoyang District Centre for Disease Control and Prevention | Conditions: Hand Foot and Mouth Disease | Phase 4 | Status: UNKNOWN